brand logo

Am Fam Physician. 2017;95(11):733-737

Clinical Question

Does supplemental testosterone improve cognitive function in memory-impaired older men with low testosterone levels?

Bottom Line

Testosterone supplementation for men 65 years or older with age-associated memory impairment and a low baseline testosterone level was not associated with significant improvements in memory or other cognitive functions. (Level of Evidence = 1b)


These investigators recruited adult men, 65 years or older, with a mean of two morning serum testosterone concentrations of less than 275 ng per dL (9.5 nmol per L). Exclusion criteria included significant cognitive impairment (Mini-Mental State Examination score < 24) and severe depression. Age-associated memory impairment was classified as subjective memory concerns and relative memory impairment (defined as more than one standard deviation below the performance scores for men 20 to 24 years of age, but not greater than two standard deviations below the scores of age-matched men) on a standard scoring tool. A total of 493 men randomly received (concealed allocation assignment) testosterone gel, 1% concentration, at an initial dosage of 5 g daily or matched placebo. The dosage of testosterone was adjusted by an unmasked study investigator to achieve a level within the mid-normal range for young men (500 to 800 ng per dL [17.4 to 27.8 nmol per L]). To maintain participant and treating-clinician masking, the dosage of placebo gel was also adjusted simultaneously. Individuals masked to treatment group assignment assessed outcomes. Complete follow-up occurred for 97.3% of participants at 12 months.

Using intention-to-treat analyses, there were no significant improvements between the testosterone and control group on measurements of delayed paragraph recall scores, visual memory, executive function, or spatial ability.

Study design: Randomized controlled trial (double-blinded)

Funding source: Government

Allocation: Concealed

Setting: Outpatient (specialty)

Reference:Resnick SM, Matsumoto AM, Stephens-Shields AJ, et al. Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment. JAMA. 2017;317(7):717-727.

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at

Continue Reading

More in AFP

More in PubMed

Copyright © 2017 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.